Skip to Main Content

Paper Details

High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma.
Cancers (Basel)
4
2021
-derived cells, Abemaciclib, CDK4/6, c-Met, c-Met-, cancer, cancer cell lines, glioblastoma, patient, patient-, patient-derived cells, patients
Author NameAffiliation
Jeong-Woo OhInstitute for Refractory Cancer Research, Samsung Medical Center
Jeong-Woo OhSamsung Advanced Institute for Health Science & Technology, Sungkyunkwan University
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSamsung Advanced Institute for Health Science & Technology, Sungkyunkwan University
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSamsung Advanced Institute for Health Science & Technology, Sungkyunkwan University
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University
  • 1 - 8

Datasets

Release 1.2